Biotech Values

[DFRAI]

Masterlongevity

I stumbled on this re your comments "tau and amyloid both important. most likely combination anti-tau and anti-abeta combination therapy in the future"

Reading some literature i noticed these comments, see below

Anavex Reports ANAVEX 2-73 Blocks Tau And Amyloid-Beta Proteins In A Preclinical Model Of Alzheimer's Disease

New York, NY/ B3C newswire / – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQB: AVXL) announces that issue 38 (2013) of the international scientific journal Neuropsychopharmacology contains a report demonstrating that ANAVEX 2-73 dose-dependently blocks Tau and amyloid-beta (“amyloid”) proteins and memory deficit in a mouse model of Alzheimer’s disease (AD)

https://www.outsourcedpharma.com/doc/anavex-reports-anavex-blocks-tau-and-amyloid-beta-proteins-0001

Do you agree with above article..their comments and conclusion?